NIH-funded research U01 cooperative agreement

Understanding genetic factors in obsessive-compulsive disorder in Latin Americans

Official title: 1/2 Trans-ancestry genomic analysis of obsessive-compulsive disorder

Funded at Univ of North Carolina Chapel Hill · NIH-10885985 · Data updated 2026-11-12

This study is looking at how genes might influence the chances of developing obsessive-compulsive disorder (OCD) in people from Latin America, and it's for anyone with OCD who wants to help us learn more about the condition to improve future treatments and support.

More Obsessive-Compulsive Disorder research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startSeptember 1, 2021
Project endJune 30, 2026
Funding year2024
Award (this year)$362,266
NIH project number5U01MH125050-04
Project IDNIH-10885985 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with obsessive-compulsive disorder, particularly those from Latin American backgrounds.

Less likely to help

Patients who do not have obsessive-compulsive disorder or are not of Latin American descent may not benefit from this research.

What this research studies

This research investigates how genetic factors contribute to the risk of developing obsessive-compulsive disorder (OCD) among individuals in Latin America. By collecting a diverse sample of 5,000 OCD cases from various clinics across Latin America and the USA, the study aims to enhance our understanding of the genetic architecture of OCD. Participants will undergo detailed clinical assessments to characterize their symptoms and any comorbid conditions. The findings could lead to improved detection, treatment, and prevention strategies for OCD based on genetic insights.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments and prevention strategies for obsessive-compulsive disorder tailored to the genetic backgrounds of patients.

How similar studies have gone: Previous research in other psychiatric disorders has shown success in using genomic analysis to uncover genetic factors, suggesting potential for similar breakthroughs in OCD.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Crowley, James Joseph — Univ of North Carolina Chapel Hill
  • Study coordinator: Crowley, James Joseph

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.